D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.14% |
| 2 | Consumer Discretionary | 12.42% |
| 3 | Healthcare | 10.3% |
| 4 | Financials | 9.14% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Madrigal Pharmaceuticals
MDGL
$12.6B
| $336K | ﹤0.01% |
1,200
-41,411
| -97% | -$7.27M |
|
3277
PUT
SolarEdge
SEDG
$2.59B
| $335K | ﹤0.01% |
7,000
| – | – |
|
3278
CRISPR Therapeutics
CRSP
$4.58B
| $334K | ﹤0.01% |
5,687
-10,308
| -64% | -$587K |
|
3279
Horizon Bancorp
HBNC
$1.03B
| $334K | ﹤0.01% |
+16,164
| New | +$330K |
|
3280
PUT
Tenet Healthcare
THC
$20.1B
| $332K | ﹤0.01% |
+9,900
| New | +$308K |
|
3281
York Water
YORW
$505M
| $332K | ﹤0.01% |
10,428
+3,624
| +53% | +$116K |
|
3282
Sibanye-Stillwater
SBSW
$5.92B
| $331K | ﹤0.01% |
136,951
-58,263
| -30% | -$179K |
|
|
PETQ
3283
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $331K | ﹤0.01% |
+12,341
| New | +$268K |
|
3284
First Horizon
FHN
$12.1B
| $330K | ﹤0.01% |
18,488
-529,401
| -97% | -$9.96M |
|
3285
Atara Biotherapeutics
ATRA
$71.2M
| $329K | ﹤0.01% |
358
-372
| -51% | -$400K |
|
3286
CALL
Bath & Body Works
BBWI
$4.01B
| $328K | ﹤0.01% |
+11,009
| New | +$318K |
|
3287
Watsco Inc
WSO
$14.9B
| $328K | ﹤0.01% |
1,840
-523
| -22% | -$95.1K |
|
|
LHO
3288
DELISTED
LaSalle Hotel Properties
LHO
| $328K | ﹤0.01% |
9,573
-1,200
| -11% | -$38.8K |
|
3289
Tejon Ranch
TRC
$476M
| $327K | ﹤0.01% |
+13,460
| New | +$334K |
|
3290
Nokia
NOK
$50.8B
| $326K | ﹤0.01% |
56,770
+26,951
| +90% | +$159K |
|
3291
BP
BP
$113B
| $325K | ﹤0.01% |
+7,555
| New | +$317K |
|
|
MR
3292
DELISTED
Montage Resources Corporation Common Stock
MR
| $325K | ﹤0.01% |
13,533
-7,816
| -37% | -$175K |
|
|
SIR
3293
DELISTED
SELECT INCOME REIT
SIR
| $325K | ﹤0.01% |
32,903
-93,355
| -74% | -$840K |
|
3294
Winmark
WINA
$1.19B
| $323K | ﹤0.01% |
2,179
-151
| -6% | -$20.7K |
|
|
BITA
3295
DELISTED
Bitauto Holdings Limited
BITA
| $323K | ﹤0.01% |
13,576
-13,667
| -50% | -$310K |
|
|
BFYT
3296
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $323K | ﹤0.01% |
9,986
-29,573
| -75% | -$901K |
|
3297
Cass Information Systems
CASS
$698M
| $321K | ﹤0.01% |
5,592
+1,037
| +23% | +$54.5K |
|
|
AMRS
3298
DELISTED
Amyris Inc.
AMRS
| $320K | ﹤0.01% |
+50,112
| New | +$301K |
|
3299
PUT
Mueller Industries
MLI
$14.1B
| $319K | ﹤0.01% |
43,200
| – | – |
|
3300
CALL
Murphy USA
MUSA
$11.3B
| $319K | ﹤0.01% |
4,300
+500
| +13% | +$34.5K |
|
Similar funds
D.E. Shaw & Co's Q2 2018 Portfolio in Review
As of Q2 2018, D.E. Shaw & Co held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
D.E. Shaw & Co's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- D.E. Shaw & Co added most to Amazon in Q2 2018, an estimated $696M increase.
- D.E. Shaw & Co's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- D.E. Shaw & Co fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- D.E. Shaw & Co's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- D.E. Shaw & Co opened 622 new positions and closed 399 in Q2 2018.
- D.E. Shaw & Co's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.